Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN2A | Q99250 | 4/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.51 |
| ▸ | CNR2 | P34972 | 5/20 | 0.47 |
| ▸ | CNR1 | P21554 | 4/20 | 0.47 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.47 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HPGDS | O60760 | 4/20 | 0.46 |
| ▸ | VCP | P55072 | 1/20 | 0.45 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8117997 | 0.95 | SCN2A (0.50) | SCN2ANPY5RCNR2CNR1CARM1 | |
| SCHEMBL7139526 | 0.95 | SCN2A (0.50) | SCN2ANPY5RCNR2CNR1CARM1 | |
| SCHEMBL7138368 | 0.91 | CNR2 (0.47) | SCN2ACNR2CNR1HPGDSVCP | |
| SCHEMBL8190593 | 0.88 | KCNH2 (0.48) | SCN2ACNR2CNR1HPGDSVCP | |
| SCHEMBL7143478 | 0.86 | KCNH2 (0.49) | SCN2ACNR2CNR1HPGDSVCP | |
| SCHEMBL8119014 | 0.85 | KCNH2 (0.51) | CNR2CNR1HPGDSVCPMAP4K4 | |
| SCHEMBL7142374 | 0.83 | SCN2A (0.58) | SCN2ANPY5RCNR2CNR1PRMT6 | |
| SCHEMBL8118669 | 0.82 | KCNH2 (0.46) | CNR2CNR1HPGDSVCPMAP4K4 | |
| SCHEMBL8137670 | 0.80 | SCN2A (0.47) | SCN2ANPY5RCNR2CNR1HPGDS | |
| SCHEMBL7142086 | 0.80 | SCN2A (0.55) | SCN2ANPY5RCNR2CNR1HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6515133-B1 | Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. | NEUROGEN CORPORATION | 2003-02-04 | — | — | US | disclosed |